yeh fair enough,
Im invested for the oncology potential rather than for septic shock, I don’t really know how anyone has a view yet on the sepsis part of the program from the limited detail of what’s been released so far. However my prediction is they’re on track for an FDA approved trial, as the phase 1 came out of the preIND discussion and now they’ve got both the lab results to show a theoretical mode of action & NOXCOVID has atleast proven safety/tolerability.
wondering what would you need to see results wise from the current program to invest?
yeh fair enough,Im invested for the oncology potential rather...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
